The results provide evidence that broadly neutralizing antibodies to HCV protect against heterologous viral infection and suggest that a prophylactic vaccine against HCV may be achievable.

• 这个结果提示我们HCV广泛中和抗体对不同准种感染均具有保作用，制作HCV保护性疫苗是可行。